Tech Company Financing Transactions
Docbot Funding Round
Docbot closed a $4 million Series A investment round on 5/25/2021. Investors included Khosla Ventures, Bold Capital Partners and Boutique Venture Partners.
Transaction Overview
Company Name
Announced On
5/25/2021
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
5270 California Ave. 100
Irvine, CA 92617
USA
Irvine, CA 92617
USA
Phone
Website
Email Address
Overview
Docbot is an artificial intelligence technology company focusing on gastrointestinal (GI) disease. Docbot's products are built on the UltivisionAI software platform for real-time image analysis, automated reporting, and analytic tools to improve patient care and clinical workflows. UltivisionAI is an investigational device and has not received FDA clearance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Ritter
Chief Medical Officer
William Karnes
Chief Operating Officer
Gabe Zingaretti
Chief Technical Officer
Tyler Dao
Co-Founder
Jason Samarasena
VP - Bus. Development
Andrew Ninh
Browse more venture capital transactions:
Prev: 5/25/2021: iLife venture capital transaction
Next: 5/25/2021: Arch Oncology venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions on this site are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs